Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia

The Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) offer different recommendations for carbapenem MIC susceptibility breakpoints for Acinetobacter species. In addition, the clinical efficacy of the intermediate category...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Yang, Ya-Sung, Wang, Yung-Chih, Kuo, Shu-Chen, Chen, Chung-Ting, Liu, Chang-Pan, Liu, Yuag-Meng, Chen, Te-Li, Lee, Yi-Tzu
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2017
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571357/
https://ncbi.nlm.nih.gov/pubmed/28652230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00661-17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi